Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa.

Journal: AIDS and behavior

Volume: 15

Issue: 6

Year of Publication: 2011

Affiliated Institutions:  Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa. John.Joska@uct.ac.za

Abstract summary 

HIV-Associated Neurocognitive Disorders (HAND) exert an impact on everyday functions, including adherence. The prevalence of and risk factors for HAND in patients commencing anti-retroviral therapy in Southern Africa are unknown. Participants from primary care clinics in Cape Town, South Africa underwent detailed neuropsychological, neuropsychiatric, and neuromedical evaluation. Using the updated American Academy of Neurology (AAN) criteria, participants were classified into categories of HAND, and demographic and clinical risk factors for HIV-dementia (HIV-D) were assessed. The prevalence of mild neurocognitive disorder (MND) and HIV-D were 42.4 and 25.4%, respectively. There were significant associations between lower levels of education and older age with HIV-D, and a trend to association with HIV-D and lower CD4 count. In a regression model, a lower level of education and male gender were predictive of HIV-D. These findings suggest that HAND are highly prevalent in primary care settings in South Africa where clade C HIV is predominant.

Authors & Co-authors:  Joska John A JA Westgarth-Taylor Jennifer J Myer Landon L Hoare Jacqueline J Thomas Kevin G F KG Combrinck Marc M Paul Robert H RH Stein Dan J DJ Flisher Alan J AJ

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  9
Identifiers
Doi : 10.1007/s10461-010-9744-6
SSN : 1573-3254
Study Population
Male
Mesh Terms
AIDS Dementia Complex
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
South Africa
Publication Country
United States